Authors:
OOSTHUIZEN W
VORSTER HH
VERMAAK WJH
SMUTS CM
JERLING JC
VELDMAN FJ
BURGER HM
Citation: W. Oosthuizen et al., LECITHIN HAS NO EFFECT ON SERUM-LIPOPROTEIN, PLASMA-FIBRINOGEN AND MACRO MOLECULAR PROTEIN COMPLEX LEVELS IN HYPERLIPIDEMIC MEN IN A DOUBLE-BLIND CONTROLLED-STUDY, European journal of clinical nutrition, 52(6), 1998, pp. 419-424
Authors:
OOSTHUIZEN W
VANDERMERWE AM
KOTZE JP
VORSTER HH
STEYN HS
Citation: W. Oosthuizen et al., DIETARY-COMPOSITION AND BODY-MASS INDEX AT DIFFERENT LEVELS OF ADDED SUGAR CONSUMPTION - THE VIGHOR STUDY, South African medical journal, 88(9), 1998, pp. 1212-1217
Citation: Hs. Kruger et al., COMBINATION ANTIOXIDANT SUPPLEMENT INCREASES RESISTANCE OF LOW-DENSITY-LIPOPROTEIN TO OXIDATION AND IMPROVES LIPOPROTEIN PROFILE OF HYPERCHOLESTEROLEMIC MEN, South African medical journal, 88(5), 1998, pp. 646-652
Authors:
JERLING JC
VORSTER HH
OOSTHUIZEN W
VERMAAK WJH
Citation: Jc. Jerling et al., EFFECT OF SIMVASTATIN, A 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR, ON THE HEMOSTATIC BALANCE OF FAMILIAL HYPERCHOLESTEROLEMIC SUBJECTS, Fibrinolysis & proteolysis, 11(2), 1997, pp. 91-96
Authors:
WALKER ARP
SITAS F
CLEATONJONES PE
VORSTER HH
WHITTAKER DE
Citation: Arp. Walker et al., DESEGREGATING HEALTH-STATISTICS AND HEALTH RESEARCH IN SOUTH-AFRICA, South African medical journal, 87(3), 1997, pp. 329-330
Authors:
WALKER ARP
SITAS F
CLEATONJONES PE
VORSTER HH
WHITTAKER DE
SEGAL I
Citation: Arp. Walker et al., DESGREGRATING HEALTH-STATISTICS AND HEALTH RESEARCH IN SOUTH-AFRICA, South African medical journal, 87(12), 1997, pp. 1701-1702
Authors:
HUMAN JA
UBBINK JB
JERLING JJ
DELPORT R
VERMAAK WJH
VORSTER HH
LAGENDIJK J
POTGIETER HC
Citation: Ja. Human et al., THE EFFECT OF SIMVASTATIN ON THE PLASMA ANTIOXIDANT CONCENTRATIONS INPATIENTS WITH HYPERCHOLESTEROLEMIA, Clinica chimica acta, 263(1), 1997, pp. 67-77
Authors:
VENTER CS
NEL CJ
VORSTER HH
JERLING JC
OOSTHUIZEN W
VELDMAN FJ
KELLERMAN JA
SMUTS CM
VERMAAK WJH
VANDERNEST DG
DERIDDER JH
Citation: Cs. Venter et al., SOLUBLE-FIBER CONCENTRATE LOWERS PLASMINOGEN-ACTIVATOR INHIBITOR-1 INBABOONS (PAPIO-URSINUS), British Journal of Nutrition, 78(4), 1997, pp. 625-637
Citation: Hh. Vorster et al., DIET AND HEMOSTASIS - TIME FOR NUTRITION SCIENCE TO GET MORE INVOLVED, British Journal of Nutrition, 77(5), 1997, pp. 671-684
Authors:
OSE L
SCOTT R
BRUSCO O
UGARTE AC
DESCAMPS O
HELLER F
PAQUOT N
SCHEEN A
BERTOLAMI MC
FORTI N
RICHTER W
SELMAIER A
ZIEGLASCH HJ
KLOER H
BADE R
WANNER C
KOESTER W
KRAEMERGUTH A
BILIANOU H
LEFKOS N
EFTHIMIADIS A
KASTELEIN J
VANDAM M
VANDEWIEL A
LINTOTT C
SUNDT E
ISTAD H
LOENNECHEN CW
UTNE E
HOLE T
SKARE S
URHEIM S
CAMPODINCO S
MORALES R
IZA A
ALVAREZ L
SY R
YEBES R
LEE CY
TAN A
QUEK S
VERMAK WJH
VORSTER HH
RAAL FJ
KELLER U
NOSEDA G
BONETTI T
CRAWFORD GM
BLOOMFIELD P
SUTHERLAND K
RYLANCE PB
BROOM J
BAKSI AK
LANT AF
HUGHES EA
Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138
Authors:
VORSTER HH
STEYN K
BADENHORST CJ
SLAZUS W
JERLING JC
JOOSTE PL
Citation: Hh. Vorster et al., PLASMA-FIBRINOGEN OF THE BLACK-POPULATION OF THE CAPE PENINSULA - THEBRISK STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1230-1230
Authors:
OOSTHUIZEN W
VORSTER HH
JERLING JC
BARNARD HC
SMUTS CM
SILVIS N
KRUGER A
VENTER CS
Citation: W. Oosthuizen et al., BOTH FISH-OIL END OLIVE OIL LOWERED PLASMA-FIBRINOGEN IN WOMEN WITH HIGH BASE-LINE FIBRINOGEN LEVELS, Thrombosis and haemostasis, 72(4), 1994, pp. 557-562
Authors:
JERLING JC
VORSTER HH
OOSTHUIZEN W
SILVIS N
VENTER CS
Citation: Jc. Jerling et al., DIFFERENCES IN PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY BETWEEN BLACKS AND WHITES MAY BE DIET-RELATED, Haemostasis, 24(6), 1994, pp. 364-368
Authors:
WALKER ARP
WALKER BF
GLATTHAR II
VORSTER HH
Citation: Arp. Walker et al., MAXIMAL GENETIC POTENTIAL FOR ADULT STATURE - IS THIS AIM DESIRABLE -RESPONSE, Nutrition reviews, 52(10), 1994, pp. 362-363
Citation: Hh. Vorster et Cs. Venter, WHY FIBRINOGEN SHOULD BE MEASURED AS PART OF THE CORONARY HEART-DISEASE RISK PROFILE, South African medical journal, 83(5), 1993, pp. 309-310